Canada Veterinary Infectious Disease Diagnostics Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Molecular Diagnostics, Immunodiagnostics, and Others), By Animal Type (Food-producing animals and Companion animals), By End-User (Veterinary Hospitals, Reference Laboratories, and In-House/Point-of-Care Laboratories), and Canada Veterinary Infectious Disease Diagnostics Market Insights Forecasts 2023 - 2033.

Canada Veterinary Infectious Disease Diagnostics Market Insights Forecasts to 2033

• The Canada Veterinary Infectious Disease Diagnostics Market Size is Growing at 6.1% CAGR from 2023 to 2033.
• The Canada Veterinary Infectious Disease Diagnostics Market Size is Expected to Reach a Significant Share by 2033.

The Canada Veterinary Infectious Disease Diagnostics Market Size is expected to reach a significant share by 2033, growing at a 6.1% CAGR from 2023 to 2033.     

Market Overview

The veterinary infectious disease diagnostics market in Canada is a term that refers to the industry involving diagnostic equipment, tests, and devices to diagnose infectious diseases in animals. It encompasses numerous methods of diagnosis such as molecular diagnosis (PCR, nucleic acid test), immunodiagnostics (ELISA, lateral flow test), microbiology (culture tests), and imaging diagnostics in veterinary medicine. It involves animals used for raising livestock, pets, and wild animals, through surveillance, prevention, and therapy of disease. The Canadian market for veterinary infectious disease diagnostics has good prospects due to increasing pet ownership, increases in livestock production, and an increased awareness of zoonoses. Market development is driven by advances in molecular diagnostics, point-of-care, and AI-driven diagnostic devices. Canadian veterinary infectious disease diagnostics is a term that is used to describe the business of diagnostic equipment, tests, and devices used to diagnose infectious diseases in animals. It involves many diagnosis methods like molecular diagnosis (PCR, nucleic acid test), immunodiagnostics (ELISA, lateral flow test), microbiology (culture tests), and imaging diagnostics in veterinary medicine. It comprises animals employed in rearing livestock, pets, and wildlife, via monitoring, disease prevention, and therapy. There are excellent market prospects for the Canadian market in veterinary infectious disease diagnostics on account of pet acquisition, production hikes in livestock, and raised recognition of zoonoses. There is growth due to breakthroughs in molecular diagnostic techniques, point-of-care technology, and artificial intelligence-enabled diagnostic tools.

Report Coverage

This research report categorizes the market for the Canada veterinary infectious disease diagnostics market based on various segments and regions forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Canada veterinary infectious disease diagnostics market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Canada veterinary infectious disease diagnostics market.

Driving Factors

Canada veterinary infectious disease diagnostics are affected by several factors. Rising pet adoption and increasing livestock farming necessitate advanced diagnostic measures to prevent disease outbreaks. Growing rates of zoonotic diseases such as avian influenza and rabies boost the demand for early and accurate detection. Government initiatives promoting animal health, alongside stringent regulations for surveillance of diseases, boost the market further. Technological advancements, including PCR-based and ELISA tests, enhance diagnostic efficiency and effectiveness. Increased veterinary healthcare expenditure and pet owner education are also important factors. The expansion of veterinary diagnostic laboratories and animal health research also aids in market development. Portable diagnostic equipment and point-of-care testing are making disease detection easier, and diagnostics are increasingly becoming more available for rural and urban Canada.

Restraining Factors

The Canada veterinary infectious disease diagnostics market is subjected to restraints such as exorbitant diagnostic test costs, limited availability in remote locations, strict regulatory clearances, and a lack of trained veterinary practitioners. Furthermore, poor awareness among pet owners and livestock farmers regarding sophisticated diagnostic techniques is also restricting market growth.

Market Segment

• The immunodiagnostics segment held the greatest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the product type, the Canada veterinary infectious disease diagnostics market is divided into molecular diagnostics, immunodiagnostics, and others. Among these, the immunodiagnostics segment held the greatest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period. This is attributed to its high accuracy, quick results, and its extensive application in the detection of infectious diseases among animals. Its growth is driven by improvements in ELISA and lateral flow tests, rising pet ownership, rising livestock disease outbreaks, and heightened demand for the early detection of diseases.

• The companion animals segment accounted for the majority of the share in 2023 and is estimated to grow at a significant CAGR during the projected timeframe.

Based on the animal type, the Canada veterinary infectious disease diagnostics market is divided into food-producing animals and companion animals. Among these, the companion animals segment accounted for the majority of the share in 2023 and is estimated to grow at a significant CAGR during the projected timeframe. This is because of increasing pet adoption, growing expenditures on veterinary healthcare, and mounting awareness about contagious diseases. Advancements in animal diagnostics, better access to animal care, and humanization of pets also fuel demand, underpinning its anticipated high CAGR in the forecast period.

• The reference laboratories segment held the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the end-user, the Canada veterinary infectious disease diagnostics market is divided into veterinary hospitals, reference laboratories, and in-house/point-of-care laboratories. Among these, the reference laboratories segment held the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period. This is attributed to their superior diagnostic power, high sensitivity, and large sample volume capacity. Growing outsourcing by veterinary clinics, increasing need for specialty testing, and technological improvements in molecular diagnostics are the major drivers for its projected strong CAGR in the forecast period.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Canada veterinary infectious disease diagnostics market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Heska
• Neogen
• Zoetis
• IDEXX
• Innovative Diagnostics
• bioMérieux
• IDVet
• Indical Bioscience

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at regional, and country levels from 2023 to 2033. Spherical Insights has segmented the Canada veterinary infectious disease diagnostics market based on the below-mentioned segments:

Canada Veterinary Infectious Disease Diagnostics Market, By Product Type

• Molecular Diagnostics
• Immunodiagnostics
• Others

Canada Veterinary Infectious Disease Diagnostics Market, By Animal Type

• Food-Producing Animals
• Companion animals

Canada Veterinary Infectious Disease Diagnostics Market, By End-User

• Veterinary Hospitals
• Reference Laboratories
• In-House/Point-of-Care Laboratories